You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 12, December 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Radiation Therapy
 •Neoplasms
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?


Merkel Cell Carcinoma Treatment With Radiation

A Good Case Despite No Prospective Studies

Arch Dermatol. 2003;139:1641-1643.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

WITH A MORTALITY rate of roughly 25%, Merkel cell carcinoma (MCC) is significantly more dangerous than melanoma (roughly 15% mortality). Although precise numbers do not exist, its incidence of approximately 400 cases per year in the United States1-2 is likely to be on the rise.3 Factors that are likely contributing to this include the aging population (mean age of MCC onset is about 70 years), greater numbers of immunocompromised organ transplant recipients (a greater incidence and severity of MCC in this population over the general public has been reported4), and, of course, the increased sun exposure habits of the past few decades. Despite a great need for the best possible care for patients with this dangerous malignancy, significant confusion persists in the literature regarding optimal management of MCC.

Specifically, despite an extensive body of literature that supports a role for radiation therapy, there persist statements that suggest radiation therapy . . . [Full Text of this Article]

WHY IS THERE A LACK OF CONSENSUS IN THE TREATMENT OF MCC?


INADEQUACY OF SURGERY ALONE AND IMPROVED OUTCOMES WITH ADJUVANT RADIATION

NEW INSIGHTS INTO RADIATION AS MONOTHERAPY
M. Isabel Longo, MD, PhD
Charlestown, Mass

Paul Nghiem, MD, PhD
Cutaneous Oncology Unit
Dana-Farber Cancer Institute
44 Binney St
Boston, MA 02115
(e-mail: pnghiem@partners.org)



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Radiotherapy Alone for Primary Merkel Cell Carcinoma
Laurent Mortier, Xavier Mirabel, Charles Fournier, Frederic Piette, and Eric Lartigau
Arch Dermatol. 2003;139(12):1587-1590.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sentinel Lymph Node Biopsy for Evaluation and Treatment of Patients With Merkel Cell Carcinoma: The Dana-Farber Experience and Meta-analysis of the Literature.
Gupta et al.
Arch Dermatol 2006;142:685-690.
ABSTRACT | FULL TEXT  

MRI of Merkel Cell Carcinoma: Histologic Correlation and Review of the Literature
Anderson et al.
Am. J. Roentgenol. 2005;185:1441-1448.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.